Webster Bank’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-273
Closed -$52K 547
2019
Q4
$52K Buy
273
+43
+19% +$7.76K 0.01% 317
2019
Q3
$39K Hold
230
0.01% 333
2019
Q2
$39K Hold
230
0.01% 332
2019
Q1
$34K Hold
230
﹤0.01% 338
2018
Q4
$31K Hold
230
0.01% 342
2018
Q3
$44K Hold
230
0.01% 340
2018
Q2
$38K Hold
230
0.01% 352
2018
Q1
$39K Hold
230
0.01% 361
2017
Q4
$38K Sell
230
-55
-19% -$9.87K 0.01% 397
2017
Q3
$58K Sell
285
-97
-25% -$22.6K 0.01% 344
2017
Q2
$93K Sell
382
-138
-27% -$32.4K 0.01% 286
2017
Q1
$124K Buy
520
+123
+31% +$28.6K 0.02% 260
2016
Q4
$83K Buy
+397
New +$82.2K 0.01% 292
2016
Q2
Sell
-1,123
Closed -$301K 220
2016
Q1
$301K Buy
1,123
+145
+15% +$41.5K 0.05% 175
2015
Q4
$305K Buy
+978
New +$291K 0.05% 171

Other funds holding AGN

Webster Bank's AGN Position: Q1 2020 in Review

Webster Bank sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 273 shares — an estimated $52K sold.

Webster Bank first reported a position in AGN in Q4 2015 and held it in 15 quarters. The position peaked at $305K in Q4 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Webster Bank reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Webster Bank sold 273 Allergan plc shares in Q1 2020, an estimated $52K.
  • Webster Bank first reported a position in Allergan plc in Q4 2015 and held it in 15 quarters.
  • Webster Bank's Allergan plc position peaked at $305K in Q4 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Webster Bank's 13F filing for Q1 2020, filed 21 Apr 2020.